Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective

類似資料

• P731: SURVIVAL IN LOWER-RISK MDS PATIENTS FROM EUMDS REGISTRY BY TWO TRANSPLANT SELECTION CRITERIA - IMPLICATIONS FOR TRANSPLANT DECISION
  著者:: Aleksandar Savic, 等
  出版事項: (2023-08-01)
• Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective
  著者:: Theo de Witte, 等
  出版事項: (2020-09-01)
• Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry
  著者:: Marlijn Hoeks, 等
  出版事項: (2020-03-01)
• S168: ERYTHROPOIETIN STIMULATION AGENTS SIGNIFICANTLY IMPROVES OUTCOME IN LOWER RISK MDS.
  著者:: H. Garelius, 等
  出版事項: (2022-06-01)
• Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes
  著者:: Louise de Swart, 等
  出版事項: (2020-03-01)